Choline-induced SLC5A7 impairs colorectal cancer growth by stabilizing p53 protein.
The members of the solute carrier (SLC) superfamily are vital membrane transporters in human cells. In the present study, we determine the expression and function of SLC5 family members in colorectal cancer (CRC). Expression analysis based on The Cancer Genome Atlas database and potential clinical relation analysis based on the ... Oncomine database indicate that SLC5A7 is downregulated and is predicted to correlate with the staging, and prognosis response of CRC. Additional results demonstrate that SLC5A7 is downregulated and correlates with good prognosis in patients with CRC. Ectopic expression of SLC5A7 either by overexpression, or uptake of choline efficiently inhibits CRC growth. Examination of the molecular mechanism reveals that SLC5A7 promotes p53 protein expression by directly interacting with and modifying p53 and disrupting the interaction between p53 and MDM2 in wild type p53 CRC cells. Our findings establish the clear correlation between SLC5A7 and tumour growth, providing a novel potential therapeutic target for CRC.
Mesh Terms:
Cell Line, Tumor, Cell Proliferation, Choline, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Humans, Protein Interaction Maps, Proto-Oncogene Proteins c-mdm2, Symporters, Tumor Suppressor Protein p53
Cell Line, Tumor, Cell Proliferation, Choline, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Humans, Protein Interaction Maps, Proto-Oncogene Proteins c-mdm2, Symporters, Tumor Suppressor Protein p53
Cancer Lett
Date: Dec. 28, 2021
PubMed ID: 34562520
View in: Pubmed Google Scholar
Download Curated Data For This Publication
235198
Switch View:
- Interactions 3